Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping

Clicks: 80
ID: 269131
2021
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #84 of 95 articles by views in acta neuropathologica communications

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Glioblastoma (GBM) is the most common malignant primary central nervous system (CNS) neoplasm in adults, and has an almost universally poor prognosis. Recently, an emphasis on genetic and epigenetic profiling has revealed a number of molecular features ...
Reference Key
viapiano2021actaspatial Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors James F. Lyon, Varshini Vasudevaraja, Kanish Mirchia, Jamie M. Walker, Robert J. Corona, Lawrence S. Chin, Ivy Tran, Matija Snuderl, Timothy E. Richardson, Mariano S. Viapiano;James F. Lyon;Varshini Vasudevaraja;Kanish Mirchia;Jamie M. Walker;Robert J. Corona;Lawrence S. Chin;Ivy Tran;Matija Snuderl;Timothy E. Richardson;Mariano S. Viapiano;
Journal acta neuropathologica communications
Year 2021
DOI
10.1186/s40478-021-01221-7
URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243907/?report=classic
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.